Evidence map

ReviewFrontiers in oncology2026

Exploring treatment models for oligometastatic castration-sensitive prostate cancer: evolution of therapeutic strategies.

Haizhong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41768233